WM
Widya Mulyasasmita
Managing Partner at BEVC
WM
Widya Mulyasasmita
Managing Partner at BEVC
United States
Overview
Work Experience
Co-Founder, Managing Partner
2023 - Current
Venture Capital firm investing in early stage companies at the intersection of science, engineering, and computation. www.bevc.com
Founding Advisor
2020
Democratizing single cell biotechnology. Team is hiring! www.partillion.com
Board of Directors
2022 - 2023
Investor and Board Observer
2022 - 2023
Sr. Principal, Healthcare
2021 - 2023
Investor and Board Observer
2021 - 2023
Board of Directors
2021 - 2023
Vice President
2020 - 2021
Red Tree VC invests in early stage companies developing therapeutics addressing significant unmet needs in oncology, neurology, and immunology. Investor & Board Observer at: Acrigen Bioscience, Excellergy, Magnus Medical, Virsti Therapeutics
Investor and Board Observer
2020 - 2021
Chief Business Officer (Founding Team)
2018 - 2020
InterVenn Biosciences leverages mass spectrometry and AI/ML to decode the human glycoproteome as a rich source of biological insight, to advance personalized, predictive, and preventative care. https://intervenn.com